Avricore Health (AVCRF) Convertible Debt (2014)

Avricore Health (AVCRF) posted quarterly Convertible Debt of $15163.7 for Q3 2014, down 49.83% quarter-over-quarter from $30225.9 in Q2 2014.

Avricore Health (AVCRF) Convertible Debt (2014) Analysis & Trends

Avricore Health (AVCRF) has reported Convertible Debt for 1 consecutive years, with $15163.7 the latest figure, recorded in Q3 2014.

  • In Q3 2014, Convertible Debt changed N/A year-over-year to $15163.7; the TTM figure through Sep 2014 stood at $15163.7 (changed N/A YoY), while the FY2014 annual figure was $30840.1, changed N/A from the prior year.
  • Convertible Debt fell to $15163.7 in Q3 2014 per AVCRF's latest filing, from $30225.9 in the prior quarter.
  • Across five years, Convertible Debt topped out at $30225.9 in Q2 2014 and bottomed at $15163.7 in Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Avricore Health 3.04 Mn 3.01 Mn -6,202.70

Historic Data

Download Data
DateValue
Sep 30, 2014 15,163.72
Jun 30, 2014 30,225.87